Do Antibodies Against The Novel Coronavirus Prevent Reinfection? : Shots – Health News – NPR

A medical worker walks in front of Transform MD Medical Center in White Plains, N.Y., where antibody testing was being offered. Pablo Monsalve/VIEW press/Corbis via Getty Images hide caption

A medical worker walks in front of Transform MD Medical Center in White Plains, N.Y., where antibody testing was being offered.

Most people infected with the novel coronavirus develop antibodies in response.

But scientists don't know whether people who have been exposed to the coronavirus will be immune for life, as is usually the case for the measles, or if the disease will return again and again, like the common cold.

"This to me is one of the big unanswered questions that we have," says Jeffrey Shaman, a professor of environmental health sciences at Columbia University, "because it really says, 'What is the full exit strategy to this and how long are we going to be contending with it?' "

He's one of many scientists on a quest for answers. And the pieces are starting to fall into place.

Antibodies, which are proteins found in the blood as part of the body's immune response to infection, are a sign that people could be developing immunity. But antibodies are by no means a guarantee a person will be protected for life or even for a year.

Shaman has been studying four coronaviruses that cause the common cold. "They're very common and so people seem to get them quite often," Shaman says. Ninety percent of people develop antibodies to those viruses, at least in passing, but "our evidence is those antibodies are not conferring protection."

That may be simply because colds are relatively mild, so the immune system doesn't mount a full-blown response, suggests Stanley Perlman, a pediatrician who studies immunology and microbiology at the University of Iowa. "That's why people get colds over and over again," he says. "It doesn't really tickle the immune response that much."

He's studied one of the most severe coronaviruses, the one that causes SARS, and he's found that the degree of immunity depended on the severity of the disease. Sicker people remained immune for much longer, in some cases many years.

For most people exposed to the novel coronavirus, "I think in the short term you're going to get some protection," Perlman says. "It's really the time of the protection that matters."

Perlman notes that for some people the symptoms of COVID-19 are no worse than a cold, while for others they are severe. "That's why it's tricky," he says, to predict the breadth of an immune response.

And it's risky to assume that experiences with other coronaviruses are directly applicable to the new one.

"Unfortunately, we cannot really generalize what kind of immunity is needed to get protection against a virus unless we really learn more about the virus," says Akiko Iwasaki, a Howard Hughes Medical Institute investigator at the Yale University School of Medicine.

An immunobiologist, she is part of a rapidly expanding effort to figure this out. She and her colleagues are already studying the immune response in more than 100 patients in the medical school hospital. She's encouraged that most people who recover from the coronavirus have developed antibodies that neutralize the coronavirus in a petri dish.

"Whether that's happening inside the body we don't really know," she cautions.

Research like hers will answer that question, eventually.

But not all antibodies are protective. Iwasaki says some can actually contribute to the disease process and make the illness worse. These antibodies can contribute to inflammation and lead the body to overreact. That overreaction can even be deadly.

"Which types of antibodies protect the host versus those that enhance the disease? We really need to figure that out," she says.

The studies at Yale will follow patients for at least a year, to find out how slowly or quickly immunity might fade. "I wish there was a shortcut," Iwasaki says, "but we may not need to wait a year to understand what type of antibodies are protective."

That's because she and other immunologists are looking for patterns in the immune response that will identify people who have long-term immunity.

Researchers long ago figured out what biological features in the blood (called biomarkers) correlate with immunity to other diseases, says Kari Nadeau, a pediatrician and immunologist at the Stanford University School of Medicine. She expects researchers will be able to do the same for the new coronavirus.

Nadeau is working on several studies, including one that seeks to recruit 1,000 people who were previously exposed to the coronavirus. One goal is to identify people who produce especially strong, protective antibody responses. She says the antibody-producing cells from those people can potentially be turned into vaccines.

Another critical question she's zeroing in on is whether people who become immune are still capable of spreading the virus.

"Because you might be immune, you might have protected yourself against the virus," she says, "but it still might be in your body and you're giving it to others."

It would have huge public health implications if it turns out people can still spread the disease after they've recovered. Studies from China and South Korea seemed to suggest this was possible, though further studies have cast doubt on that as a significant feature of the disease.

Nadeau is also trying to figure out what can be said about the antibody blood-tests that are now starting to flood the market. There are two issues with these tests. First, a positive test may be a false-positive result, so it may be necessary to run a confirmatory test to get a credible answer. Second, it's not clear that a true positive test result really indicates a person is immune and, if so, for how long.

Companies would like to be able to use these tests to identify people who can return to work without fear of spreading the coronavirus.

"I see a lot of business people wanting to do the best for their employees, and for good reason," Nadeau says. "And we can never say you're fully protected until we get enough [information]. But right now we're working hard to get the numbers we need to be able to see what constitutes protection and what does not."

It could be a matter of life or death to get this right. Answers to these questions are likely to come with the accumulation of information from many different labs. Fortunately, scientists around the world are working simultaneously to find answers.

You can contact NPR Science Correspondent Richard Harris at rharris@npr.org.

View original post here:
Do Antibodies Against The Novel Coronavirus Prevent Reinfection? : Shots - Health News - NPR

Changes to the Roche Enlarged Corporate Executive Committee – Benzinga

Basel, 11 May 2020 - Roche today announced that Michael Varney (1958) Ph.D., and Head of Genentech Research and Early Development (gRED) since 2015, will retire from the company at the end of July. Aviv Regev (1971), Ph.D., and currently Chair of the Faculty, Core Institute Member, and member of the Executive Leadership Team of the Broad Institute of MIT and Harvard, as well as Professor of Biology at MIT and Investigator of the Howard Hughes Medical Institute, will join Genentech as the new Head of gRED and will become a member of the enlarged Corporate Executive Committee as of 1 August 2020. She will be based in South San Francisco.

Commenting on the appointment, Roche's CEO Severin Schwan said: "I am very excited to have Aviv Regev joining us. She brings a rare combination of expertise that will help us unlock even more possibilities in data-based drug discovery and development." Schwan further commented: "I have tremendous gratitude for Mike's many contributions over the past fifteen years including expanding our drug platform capabilities and the positive impact he has made to the strength of our pipeline. I wish him continued happiness and health in his retirement."

Aviv Regev has a Ph.D. in computational biology and Master of Science from Tel Aviv University. Through her pioneering efforts she is a leader in deciphering molecular circuits that govern cells, tissues and organs in health and their malfunction in disease. In particular, she has pioneered assays for RNA sequencing in single-cells, machine learning algorithms for distilling biological knowledge from the resulting information, and many of the first demonstrations of how to yield foundational new insights into an extraordinarily wide range of molecular circuits, systems, and fields, including immunology, neurobiology, development, inflammatory disease, cancer, and evolution. In doing so, her groundbreaking work is helping to answer the deepest and most general of biological questions -- how cells and their circuits function and rewire, and how these dynamics underlie health and malfunction in disease.

In addition to her current roles, she holds further responsibilities as founding co-chair of the international Human Cell Atlas project and founding Director of the Klarman Cell Observatory at Broad Institute. Prior to joining MIT and the Broad, she was a Bauer Fellow for the Center for Genomics Research at Harvard University. Beyond her many scientific publications, she has been recognized with numerous designations and awards such as member of the National Academy of Sciences, recipient of the Paul Marks Prize from Memorial Sloan Kettering Cancer Center, and the Innovator Award from the International Society for Computational Biology. She serves on multiple corporate advisory, scientific advisory, and journal editorial boards, and served on the advisory committee to the National Human Genome Research Institute at the National Institutes of Health. About Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit http://www.roche.com.

All trademarks used or mentioned in this release are protected by law.

Roche Group Media Relations Phone: +41 61 688 8888 / e-mail: media.relations@roche.com - Nicolas Dunant (Head) - Patrick Barth - Daniel Grotzky - Karsten Kleine- Nathalie Meetz - Barbara von Schnurbein

Visit link:
Changes to the Roche Enlarged Corporate Executive Committee - Benzinga

Expert says he’s now ‘begging the Government’ to change guidelines on face masks – Newstalk

An immunology expert says he is now 'begging the Government' to change the guidelines and recommend the wearing of face masks in public.

It comes amid increasing calls for clarity and guidance for the public on face coverings as part of the phased reopening of the country in the coming weeks and months.

The National Bus and Rail Union (NBRU) has called for the compulsory wearing of masks for all commuters to protect staff and 'enhance customer confidence'.

Officials have indicated that the use of face coverings in the community will be part of the efforts to ease social distancing measures over the summer.

However, the public has not yet been advised by health officials to wear masks when out and about.

Luke ONeill - Professor of Biochemistry at the School of Immunology at Trinity College Dublin - spoke to The Pat Kenny Show about why he believes people should be covering their faces while out shopping or on public transport.

Expert says he's now 'begging the Government' to change guidelines on face masks

00:00:00 / 00:00:00

He said the situation regarding masks in Ireland remains gob-smacking

He observed: I go into work at the moment, and Im on the DART: nobody was wearing a mask.

I went out to Tesco and got myself a sandwich for lunch: again, nobody was wearing a mask.

Prof ONeill noted that the evidence regarding mask-wearing has grown stronger and stronger and stronger.

He said: "The Royal Society, a very famous institution, issued a big report two days ago summarising the evidence the best brains in the world say you have to wear a mask in a supermarket or on public transport.

Im begging the Government now to change the guidelines.

He said its vital there are adequate supplies of protective equipment for healthcare workers and that the public is well-informed on how to use masks properly.

However, he stressed: The evidence is clear: it helps decrease spread. Its obvious in a way, isnt it?

Im pretty sure the Government will change the guidelines on this - we hope so soon."

Prof O'Neill also stressed that people shouldn't feel awkward about wearing masks in public.

He suggested: "Don't worry about yourself - it's the other person you're protecting. That's the key thing."

Main image: File photo. Photograph: Sasko Lazarov / RollingNews.ie

View original post here:
Expert says he's now 'begging the Government' to change guidelines on face masks - Newstalk

The way to beat coronavirus (COVID-19) from testing to vaccination – ILoveQatar.net

Immunology expert Dr. Richard OKennedy, Qatar Foundation Vice President for Research, Development, and Innovation, explains how COVID-19 testing works - and why developing a vaccine takes time.

The rapid pace at which coronavirus continues to spread across the world has inevitably raised questions about testing, vaccines, and potential treatments including why testing for the virus appears difficult and time-consuming, how long a vaccine will take to develop, and how it will work once it has been developed.

Dr. Richard OKennedy, Qatar Foundation Vice President for Research, Development, and Innovation, and an immunology expert, says:

Adding to the complexity of developing accurate testing kits is the urgency with which the world is seeking these tests. However, as Dr. OKennedy points out, the companies developing them need to ensure they are validated and approved before they can move to the mass manufacturing stage, with the process rendered even more difficult due to the speed with which coronavirus (COVID-19) cases worldwide have risen:

A vaccine for coronavirus (COVID-19) has been the subject of discussion since the start of the outbreak, with such conversations often failing to recognize that the vaccine development process can take as long as 10-15 years. However, given the severity and ever-changing consequences of the current global pandemic, specialists in several countries are working around the clock on research that is aimed at developing a vaccine within a much shorter timescale.

As Dr. OKennedy explains, the immune system is essentially a series of defense mechanisms within the human body. People can play their own part in ensuring something that may look to attack their body does not have the opportunity to do so, which explains why healthcare professionals unanimously agree that the best course of action is to keep washing hands and observe social distancing guidelines.

When an infection does get through these precautions, the immune system creates antibodies to fight and counteract it. However, every so often, a virus such as the coronavirus (COVID-19) mutates and evades the human immune system.

Dr OKennedy said

A vaccine can be described as something that activates or primes the immune system. The way the polio vaccine the success rate of which has contributed to the near-elimination of polio worldwide works, for instance, is that the human immune system is exposed to a small, inactive dose of the virus to activate an immune response. This immune response allows the body to defend itself against the virus.

Dr. OKennedy said.

The consequences of prematurely introducing a vaccine that turns out to be unsafe are potentially severe. In order to prevent this, vaccines go through rigorous testing and clinical trials, contributing to the timescales involved in introducing them.

In the meantime, the global medical community is exploring potential treatments using combinations of existing drugs. One that has gained a high profile is Chloroquine, an antimalarial drug, but its effectiveness is subject to trial results.

Dr. OKennedy said:

Source: QF

Liked this article? Share it!

Excerpt from:
The way to beat coronavirus (COVID-19) from testing to vaccination - ILoveQatar.net

Coronavirus isolation affects your brain a neuroscientist explains how, and what to do about it – ABC News

After weeks of living in the coronavirus shutdown, for people in many parts of Australia restrictions are finally beginning to lift.

But have you noticed that as the weeks passed in isolation, you found you couldn't think as clearly, that you were lethargic, less productive, your mental health deteriorated, or that your attention span dwindled?

Or, paradoxically, maybe you had a strange surge in productivity?

But iso life isn't completely over yet. So let's take a look at how living in isolation affects the brain, and what we can do about it.

We can get a better understanding of how our brains are responding to COVID-19 isolation when we look at past research on people and animals who have been isolated. For example, people travelling in space or imprisoned in solitary confinement, or animals in captivity all give us clues.

When we are faced with danger, our brains release hormones that trigger the "flight or flight" response.

This serves two main functions it helps prepare our body to fight the threat or escape to safety, and it also encourages us to band together.

The evolutionary basis for this is survival a cohesive group is more likely to survive a threat.

Get the latest health news and information from across the ABC.

The thing is, the body reacts the exact same way to modern-day stresses, such as dealing with the COVID-19 pandemic.

And because this situation is constant for many of us, we find ourselves in a state of chronic stress.

Chronic stress affects the cells in our body right down to the level of our genes.

This explains why some people are having a hard time holding things together, while others are finding that they are the most productive they've been in years.

Stress is fundamentally a process that allows our body to function most effectively, to meet the challenges faced at the time which is why some people report performing much better during isolation.

However, a body and brain that are chronically stressed are focused on survival.

Being in survival mode comes at the expense of our most sophisticated behaviours our decision-making skills, our problem solving, our creativity and we revert back to our more primitive behaviours, such as anger, fear and aggression.

During chronic stress, the part of our brain involved in initiating the fight or flight response, and the generation of our emotions, a region called the amygdala, grows in size as it adapts to the high levels of stress hormones, such as cortisol.

However, larger amygdalas are correlated with more aggression across all species which is why you might find yourself angrier or more emotional.

When we're stressed, our brain releases a little burst of the hormone oxytocin, as a coping mechanism.

Oxytocin is responsible for that feeling of being close and connected to someone and it drives us to seek connection with others.

Why does our brain release a "bonding" hormone when we're stressed?

It serves a really important evolutionary purpose it is trying to help us survive.

It makes us crave that connection with someone, so that when we're stressed, we seek safety in numbers. We reach out for help, we talk our problems through with a friend, and we ultimately feel better.

Researchers have also observed the part of our brain involved in decision making, known as the prefrontal cortex, shrinking and becoming more disconnected from other brain areas in response to long-term stress. So if you've been struggling to focus and be productive, this could be why.

The prefrontal cortex is important for problem solving, attention, regulating our emotions, and our complex behaviours like personality and creativity.

Breaking down the latest news and research to understand how the world is living through an epidemic, this is the ABC's Coronacast podcast.

Just because there's a biological reason behind why your brain's functioning a little differently right now doesn't mean you can't take control.

Here are five aspects of your life that you might feel are a little wonky at the moment, and what you can do about it.

For over 50 years, we have known that people who are more socially isolated are more likely to die.

The 29 per cent increased risk in mortality for people who have spent years in social isolation is largely due to the effects of chronic stress on the body.

When we are socialising with someone we like, our brain releases a cocktail of hormones and neurotransmitters, which helps us feel closer to that person, happier, and even reduces pain.

Socialising activates our brain's reward system, which makes us feel good.

This is the same part of the brain that makes food taste great when we're hungry, or is responsible for you feeling elated when your favourite sports team wins a game. It also drives addiction.

And socialising doesn't just make us bond with people, it also makes us feel better, by reducing the levels of stress hormones, like cortisol, in our body.

You might have noticed that talking on the phone to a loved one leaves you feeling better than texting alone does.

This is because text messaging activates the brain's reward pathway, but it doesn't seem to result in the release of oxytocin.

In addition to social connection, it seems that connection to self is important too. Mindfulness, meditation and yoga have been shown to help reverse stress-related changes in the brain.

Social media makes it possible for us socialise far and wide. Reach out to friends online, call your parents, and learn how to practice mindfulness or meditation.

Social deprivation is one thing. What about sensory deprivation?

Many of us are already living in small apartments in a concrete jungle, and being in isolation has restricted our ability to get outdoors.

When mice are housed in isolation, the levels of certain growth factors in their brain changes after just two weeks.

We have the same growth factors in our brain, though to date it has not been possible to measure this in living humans.

These growth factors are a bit like a brain "fertiliser," and keep the cells in the brain working optimally, and helping them survive.

So it isn't surprising to hear that after mice had been placed in one month of social isolation, neurons in the sensory and motor regions of the brain had shrunk by 20 per cent.

Having low levels of these growth factors are associated with an increased risk of anxiety and depression, which is why you may have noticed your mental health deteriorate.

The good news is, we know that spending time in nature can help reverse the effects stress on the body. Just 20 minutes in a green space reduces our stress hormone cortisol levels by 18.5 per cent.

Head to the backyard for a dose of nature, or if you're in an apartment with no nature to gaze at, be sure to get to a green space for your exercise.

Depression disrupts sleep. When we look at the brains of people who are depressed, scientists have found that genes involved in our sleep-regulating circadian rhythm change.

Even if you aren't feeling depressed, you may still have noticed your sleep cycles change in isolation.

Much of this is likely due to a disruption in your routine, and a lack of exposure to light. Exposure to light delays the release of sleep-inducing melatonin.

Some of us are having strange dreams, or even nightmares. In isolation, many of us are sleeping longer and waking up more naturally, which is associated with having heightened dream recall.

Our dreams are composed of elements of our daily life experiences. When we sleep, our important memories throughout the day are shuttled into long-term memory storage.

Some of this occurs in the "shallow" stage of sleep, known as the REM stage, where we experience dreams and are easily woken. You won't remember your dreams if you are woken up in deep sleep.

We cycle from REM sleep to deep sleep and back to REM sleep approximately every 90 minutes.

Withdrawal from our daily routine has starved our dreams of "inspiration," forcing our subconscious to draw more heavily from past experiences.

The more anxiety we feel about our life, the more negative our dreams tend to be.

To help improve your sleep, try sticking to a routine and avoid screen time for at least an hour before bed. And lay off the alcohol it reduces the quality of your sleep.

Many of us are finding that we spending more time vegetating on the couch and aren't getting enough or any physical activity.

Among many other things, exercise increases blood flow to the brain, and raises the levels of these "brain fertiliser" growth factor compounds. It also stimulates the formation of new brain cells.

New brain cells are integrated into our brain circuits and are crucial for learning and memory.

Feeling forgetful and struggling to learn during isolation? Thirty minutes of moderate intensity exercise every second day may help change this.

In fact, just 10 minutes of exercise may improve our attention for the following two to four hours, so if you're struggling to focus, get that blood pumping.

Want even more science, health and tech? Join the conversation on Facebook.

Have you found yourself overeating or binge-eating? Emotional or comfort eating occurs when we try to suppress negative emotions with food.

Our body's stress response takes a lot of energy, which is why stress increases our preference for calorie rich foods.

Those tasty sweets result in the release of release of dopamine in our brain's reward centre. This is why they make us feel good in the short term.

Unfortunately, long term high-fat or high-sugar diets impair brain function by increasing inflammation and reducing neuroplasticity, that is, how adaptable our brain is.

This is why you may be struggling to learn after binging on junk food over the past month.

Give your isolation brain a boost by laying off the high-sugar or high-fat treats. Have healthy snacks on hand instead, like fruit, vegetables and nuts.

Dr Lila Landowski is a research fellow in neuroscience and brain plasticity at the School of Medicine, University of Tasmania.

Loading...

Read the original:
Coronavirus isolation affects your brain a neuroscientist explains how, and what to do about it - ABC News

COVID-19 pandemic NEUROSCIENCE ANTIBODIES AND ASSAYS Market 2019 Future growth, new developments, and industry analysis Research Report – Cole of…

Research report on NEUROSCIENCE ANTIBODIES AND ASSAYS Market size | Industry Segment by Applications, by Type, Regional Outlook, Market Demand, Latest Trends, NEUROSCIENCE ANTIBODIES AND ASSAYS Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025. Analyzes current market size and upcoming 5 years growth of this industry.

Report Covers Global Industry Analysis, Size, Share, CAGR, Trends, Forecast And Business Opportunity.

Download Premium Sample Copy Of This Report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=268&RequestType=Sample

Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market to reach USD 5.1 billion by 2025.

Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience antibodies and assays techniques are some of the factors contributing to the growth of this segment.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product oReagents oInstrumentsBy TechnologyoImmunoassayoMolecular DiagnosticsBy End UseroResearch InstitutesoHospitalsBy Regions:oNorth AmericaoU.S.oCanadaoEuropeoUKoGermanyoAsia PacificoChinaoIndiaoJapanoRest of the World

Furthermore, years considered for the study are as follows:

Historical year 2015Base year 2016Forecast period 2017 to 2025

Some of the key manufacturers involved in the market are. Thermo Fisher Scientific, Abcam, Bio-Rad, Merck KGAA, Cell Signaling Technology, Genscript, Rockland Immunochemicals. Bio Legend, Santa Cruz Biotechnology, Tecan, F. Hoffmann-La Roche, Siemens. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS in Market Study:

oKey Consulting Companies & AdvisorsoLarge, medium-sized, and small enterprisesoVenture capitalistsoValue-Added Resellers (VARs)oThird-party knowledge providersoInvestment bankersoInvestors

Have Any Query Or Specific Requirement? : https://brandessenceresearch.biz/Request/Sample?ResearchPostId=268&RequestType=Customization

Table of Content:

Market Overview:The report begins with this section where product overview and highlights of product and application segments of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company:Here, the competition in the Worldwide Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market is analyzed, By price, revenue, sales, and market share by company, market rate, competitive situations Landscape, and latest trends, merger, expansion, acquisition, and market shares of top companies.

Company Profiles and Sales Data:As the name suggests, this section gives the sales data of key players of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market.

Market Status and Outlook by Region:In this section, the report discusses about gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User:This section of the research study shows how different end-user/application segments contribute to the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market.

Market Forecast:Here, the report offers a complete forecast of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Research Findings and Conclusion:This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://apnews.com/bb6aa419e9306aa39c0967cbaf8359f7

https://www.marketwatch.com/press-release/at-1729-cagr-intelligent-vending-machine-market-2019-share-upcoming-trends-segmentation-and-forecast-to-2025-2020-04-01

https://apnews.com/236d33cfeea1ad301626edb3bb553db1

See the original post:
COVID-19 pandemic NEUROSCIENCE ANTIBODIES AND ASSAYS Market 2019 Future growth, new developments, and industry analysis Research Report - Cole of...

Our pupil can follow rhythms that arise in the environment – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.May 8 2020

When we find something particularly beautiful or impressive, we literally get big eyes: Our pupils dilate. The pupil controls how much light enters the eye and falls on the retina. When there is a lot of light, the pupil contracts; when there is little light, it opens again. Neuroscientists from the German Primate Center (DPZ) - Leibniz Institute for Primate Research and the European Neuroscience Institute Gttingen have now found out in a study of humans and rhesus monkeys that the movement of the pupil is not only reflexively controlled by the amount of incident light, but unconsciously also by our mind. Thus, the pupil can follow rhythms that arise in the environment. In this way, the opening of the pupil is optimally adapted to our environment which enhances perception (Journal of Neuroscience).

Sensory impressions from our environment are often rhythmic, not only when we hear, but also when we see. For example, the blue light of a passing ambulance flashes about 120 times per minute. We also react unconsciously to visual events in our environment, which can be registered by our senses as regular patterns. From these patterns our brain can, for example, deduce when the next flash of blue light will hit the eye and prepare itself for it.

An important factor in vision is the adjustment of the pupil diameter. Smaller pupils provide a sharper image, while larger pupils allow more light to reach the retina, making it more likely that even weak stimuli will be processed at all. Pupil diameter is controlled by the pupillary reflex, which automatically, i.e. without our knowledge or intention, adjusts the pupil muscles to the incidence of light. But not all relevant environmental information is contained in the amount of incident light alone. Computations are therefore required in the brain that go beyond the capabilities of a reflex to take into account all available information. The aim of this study, funded by the German Research Foundation (DFG), was to find out whether and to what extent pupil dynamics are controlled fully automatically or whether they are also influenced by more complex rhythms in the environment.

For the investigations, pupil movements of two male rhesus monkeys (Macaca mulatta) and several test subjects of both sexes were measured using a high-speed video camera, while the subjects were shown sequences of images of human faces at a temporal frequency of two hertz. A dark background was shown between the images. The alternation of background and image causes the pupil to dilate and contract in rhythm with the images. During the experiments, the order of the images was manipulated - they were grouped in pairs so that a particular image always followed a particular other image. Thus, there are two rhythms to which the pupil reacts: a fast one (two hertz), which results from the alternation of image and background, and one at half that pace (one hertz), which results from the arrangement of the images as pairs. The sequence of the pairs is not given by the light itself, and therefore requires an additional computation of environmental rhythms in the brain. Since the luminance of the faces in all pictures as well as the dark background in the "pauses" remained unchanged, but the arrangement of the pictures varied, conclusions could be drawn about the influence of this additional computation on pupil dynamics.

In addition to the structured sequence, randomly arranged images with the same frequency (two hertz) were shown. A comparison of the results between structured and unstructured image sequences at the same image frequency shows that in both species studied the pupil follows not only the light-related rhythm of the images, but also the more complex rhythm of the pairs. Pupil movement in a slow (one hertz) rhythm keeps the pupil open longer, as if a pair should not be interrupted by the closing of the pupil. This allows more light to reach the retina.

The additional information contained in the environment thus complements the information already reaching the retina via the incident light."

Caspar Schwiedrzik, head of the junior research group "Perception and Plasticity"

Furthermore, the study was able to show that this contributes to an improvement in perception, even if the test subjects are not aware that there is a rhythm in the environment. "Pupil control is therefore not purely reflexive, but is also influenced by our unconscious thoughts," adds Schwiedrzik.

Source:

Journal reference:

Schwiedrzik, C.M., et al. (2020) Pupil diameter tracks statistical structure in the environment to increase visual sensitivity. Journal of Neuroscience. doi.org/10.1523/JNEUROSCI.0216-20.2020.

More here:
Our pupil can follow rhythms that arise in the environment - News-Medical.Net

Our pupils follow rhythms that arise in the environment – Tech Explorist

Our pupils also dilate when we see someone were attracted to. It controls the amount of light entering the eye and hits the retina. To control the amount of light that hits the retina, our iris, the colored part, acts as a shutter, expanding or contracting to determine how much light gets through the pupil.

Neuroscientists from the German Primate Center (DPZ) Leibniz Institute for Primate Research and the European Neuroscience Institute Gttingen have now discovered in an investigation of humans and rhesus monkeys that the measure of incident light doesnt just reflexively constrain the movement of the pupil, but unconsciously also by our brain. In this way, the pupil can follow rhythms that rise in the environment.

In this manner, the opening of the pupil is optimally adapted to our environment, which enhances perception.

Adjusting pupil diameter in accordance with environmental regularities optimizes information transmission at ecologically relevant temporal frequencies.

Pupil diameter is constrained by the pupillary reflex, which naturally adjusts the pupil muscles to the frequency of light. However, not all essential environmental information is contained in the amount of incident light alone. Computations are subsequently required in the brain that go past the abilities of a reflex to take all accessible data. The point of this investigation, supported by the German Research Foundation (DFG), was to see if and to what degree pupil dynamics are controlled completely naturally or whether increasingly complex rhythms in the earth additionally impact them.

A high-speed video camera was used to measure pupil movements of two male rhesus monkeys (Macaca mulatta) and several test subjects of both sexes. On the other hand, subjects were shown sequences of images of human faces at a temporal frequency of two hertz.

A dark background was shown between the images. The alternation of background and image causes the pupil to dilate and contract in rhythm with the images. During the experiments, the order of the images was manipulated they were grouped in pairs so that a particular image always followed a specific other image.

Thus, there are two rhythms to which the pupil reacts: a fast one (two hertz), which results from the alternation of image and background, and one at half that pace (one hertz), which results from the arrangement of the images as pairs. The light itself does not give the sequence of the pairs, and therefore requires an additional computation of environmental rhythms in the brain.

Since the luminance of the faces in all pictures, as well as the dark background in the pauses, remained unchanged, but the arrangement of the pictures varied, conclusions could be drawn about the influence of this additional computation on pupil dynamics.

In addition to the structured sequence, randomly arranged images with the same frequency (two hertz) were shown. A comparison of the results between structured and unstructured image sequences at the same image frequency shows that in both species studied, the pupil follows not only the light-related rhythm of the images but also the more complicated rhythm of the pairs. Pupil movement in a slow (one hertz) rhythm keeps the pupil open longer as if a pair should not be interrupted by the closing of the pupil. This allows more light to reach the retina.

Caspar Schwiedrzik, head of the junior research group Perception and Plasticity, said,The additional information contained in the environment thus complements the information already reaching the retina via the incident light. Furthermore, the study was able to show that this contributes to an improvement in perception, even if the test subjects are not aware that there is a rhythm in the environment. Pupil control is therefore not purely reflexive, but is also influenced by our unconscious thoughts.

More:
Our pupils follow rhythms that arise in the environment - Tech Explorist

Gaze and pupil dilation can reveal a decision before it’s made | Penn Today – Penn: Office of University Communications

The direction in which people look and how dilated their pupils get can reveal the decision theyre about to make, according to research published in the Proceedings of the National Academy of Sciences by Penn neuroscientist Michael Platt and colleagues. These biomarkers also offer clues into the underlying biological processes at play as choices get made.

Understanding this can help explain why people make the decisions that they do, why one individual might make a different decision than another, even why people who seem to make the same decision might do so for different reasons, in terms of the biology, says Platt, a Penn Integrates Knowledge professor with appointments in the Wharton School, School of Arts & Sciences, and Perelman School of Medicine.

The work grew out of conversations between the Wharton Neuroscience Initiative, which Platt runs, and one of its partners, Vanguard, about why people more frequently make unwise financial decisions as they age. The discussion soon turned to broader questions about decision making, something Platt, postdoctoral researcher Feng Sheng, and former postdoctoral researcher Arjun Ramakrishnan opted to test with a well-known concept called loss-aversion.

People want to avoid a loss, even if doing so comes at the expense of a gain. Its why people buy insurance, Platt says. We seem to be really afraid of losses, of any possible risk of losing money or anything else.

One theory in the field says that losses are felt more profoundly than the happiness derived from a gain. To build on that notion, the Penn team created a gambling-task experiment that tracked eye movement and pupil dilation during the decision-making process. Ninety-four participants, each wearing an eye-tracking headset, went through two rounds of 100 trials. In each trial, they had to accept or reject a gamble that offered a possible gain or loss of $1 to $10.

For a study like this to succeed, participants must feel that their decisions arent purely hypothetical, so at the outset, the research team gave every person $10. They gambled with that over the 200 trials, Platt says. Whatever they ended up winning, they took home.

With dataset in hand, the research team then turned to a computational model based on a decision-making theory that says that the brain sequentially gathers information over time, then uses that evidence to tip the scales in one direction or another. Platt explains with the example of a yellow traffic light. As you approach a yellow light, do you hit the brakes or the gas?

It depends on where your eyes go, when, and for how long. Evidence for stoppinga person walking nearby, other cars on the roadgo into one bucket, and evidence for continuing, like a clear road ahead or beautiful weather, go into other. When one fills up, its the equivalent of hitting a threshold and you make a decision, he says. We know now that this is what our brain does, accumulating evidence toward one decision or another.

Neuroscientists also know that the more someone looks at a single spot or item, the more of a boost it gets compared to other information that could have been gathered. That affects the choice made. Thats why eye-tracking is really important and useful. Where people look indicates their biases, the information thats important to them, and it becomes highly predictive of the decision theyll make.

In the case of the gambling task, the two buckets comprised acceptance or rejection of each gamble. Platts team surmised that, because people are generally more sensitive to loss, for each gamble they would spend more time looking at the loss option over the gain. For the most part, that turned out to be true.

But the researchers also noticed that some participants rejected outright any gamble with a potential loss, regardless of the amount. In the rare moments that they challenged the default, opting instead to take the gamble, their eyes began to dilate half a second before they made the decision. We could predict when someone was about to accept a gamble just by the increased size of their pupil, Platt says.

Ultimately, understanding how this particular neurological process works could allow for personalized interventions. For example, knowing that where a person looks and for how long influences decision making, its possible that subtle suggestionslarger or bolder font on a page, for instancecould discreetly direct the gaze.

Platt and colleagues are working on a large study to test that theory, and preliminary data so far confirm their hypotheses. Theyre also conducting a study in conjunction with Vanguard to look at whether these biological processes and the biomarkers associated with them change systematically as people get older. Its an extension of the study they just published in PNAS.

All of this work fits into Platts overall research program. Were driven to understand why people make the decisions that they do and how using the tools of neuroscience can help, he says. Now we have two candidate biomarkerswhere people look and the size of their pupilsthat can tell us a lot of about the internal processes, and given the state of this technology, are easy and cheap to measure.

Michael Plattis the James S. Riepe University Professor in theDepartment ofPsychology in theSchool of Arts & Sciences, theDepartment ofNeurosciencein thePerelman School of Medicine, and theMarketingDepartment in theWharton School at the University of Pennsylvania.

Feng Sheng is a postdoctoral researcher in theDepartment of Marketingin theWharton School at the University of Pennsylvania.

Arjun Ramakrishnan, formerly a postdoctoral researcher in thePlatt Labs, is currently an assistant professor at the Indian Institute of Technology, Kanpur.

Read more here:
Gaze and pupil dilation can reveal a decision before it's made | Penn Today - Penn: Office of University Communications

Stars Host Free Live, Online Classes with Varsity Tutors – Look to the Stars

As part of its response to COVID-19 school closures, Varsity Tutors today announced that it has partnered with celebrity personalities from the worlds of entertainment, sports, and science to launch StarCourse a series of live, online celebrity-led classes. These classes will be available for free to kids and parents as part of Varsity Tutors Virtual School Day.

Students attending the free live classes will have the opportunity to take a class with Emmy Award winner Julianne Hough, two-time champion of Dancing with the Stars and creator of KINRGY; to learn health and wellness practices with gold medal gymnast, Aly Raisman; to study all things space with Leland Melvin, a former NFL star turned NASA astronaut; and to talk neuroscience with Mayim Bialik, a PhD scientist and star of the hit show The Big Bang Theory. Each of these celebrity instructors will host their own live classes throughout the month of May.

These live classes are a phenomenal addition to the Virtual School Day initiative that weve established for families impacted by coronavirus school closures, said Brian Galvin, Chief Academic Officer for Varsity Tutors. During this time, we feel families are looking for ways to keep their children both engaged and learning. Were thrilled to be able to work with the celebrity instructors as they share their knowledge and expertise in the subjects theyre passionate about.

People were born to move, create, and imagine, Hough said. Through my class, I hope to help kids connect with all three pastimes. Ill be teaching two movement classes that blend choreography and fitness, and that allow kids to express themselves creatively while doing it.

Bialik added, Neuroscience is definitely esoteric, but I think there are aspects of it that can be brought down to the level of an interested child easily. My class is a chance to lift the clouds around neuroscience and help kids discover all thats interesting about this area of study.

World champion gymnast Raisman noted, "I spent a lot of time as a gymnast working on my balance and strength, which was a big part of my success in the gym. Now, I have learned to apply the same basic principles to my everyday life and I want to help encourage people of all ages to prioritize their overall health and wellness. "

After injuries ended my football career, I decided to attend graduate school and study engineering thanks to a former professors influence, Melvin said. I want to pay that example forward and inspire students to reach for the stars.

The celebrity-led classes are a part of a bigger Varsity Tutors initiative to provide access to engaging, interactive classes for free. In March, Varsity Tutors launched Virtual School Daya remote learning program that includes live classes and educational resources intended to help parents fill their childrens day with enriched learning. Virtual School Day provides students with over 50 hours per week of instruction. Each class is led by an expert tutor with experience in the course topic, as well as familiarity with virtual instruction. Classes refresh weekly, with age-appropriate options for grades K-12.

Parents interested in registering for the celebrity-led classes or Virtual School Day should visit http://www.virtualschoolday.com to sign up.

Originally posted here:
Stars Host Free Live, Online Classes with Varsity Tutors - Look to the Stars